PROMIS NEUROSCIENCES INC. Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount
PROMIS NEUROSCIENCES INC. (PMN) reported Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount of -$5.96 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-25.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate · last filed 2026-03-25
- PROMIS NEUROSCIENCES INC. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2025 was -$5.96M, a 929.01% decline from fiscal 2024.
- PROMIS NEUROSCIENCES INC. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2024 was $719.00K.
- PROMIS NEUROSCIENCES INC. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2023 was -$3.56M.
- PROMIS NEUROSCIENCES INC. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2022 was -$4.89M.
| Period end | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount 12 month |
|---|---|
| 2025-12-31 | -$5.96M 10-K · filed 2026-03-25 |
| 2024-12-31 | $719.00K 10-K · filed 2025-03-31 |
| 2023-12-31 | -$3.56M 10-K · filed 2025-03-31 |
| 2022-12-31 | -$4.89M 10-K · filed 2024-04-01 |
| 2021-12-31 | -$2.46M 10-K · filed 2023-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Anixa Biosciences Inc (ANIX) | United States | $0.096B | |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |